Purchase of AAA Netspot - Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours

Official notice

Authority: The Royal Marsden NHS Foundation Trusts (NHS & healthcare)

GoodsAward procedure without prior publication of a call for competition

Sectors: Medical Devices & Pharma (33) Delivery: London (UKI)

Awarded value£475,200published contract · exc. VAT

Awarded 7 Apr 2021no call for competition

Awarded to Advance Accelerator Applications

What is being bought

Published requirement description

AAA Netspot is a Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours

CPV: Medical equipments, pharmaceuticals and personal care products

The lotProcurement structure

single lot · no lot value published

Lot #1The Royal Marsden Hospital NHS Foundation Trust needs to purchase AAA Netspot vials…

The Royal Marsden Hospital NHS Foundation Trust needs to purchase AAA Netspot vials which is a Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours

Delivery: London

Procedure terms & legal framework

From the official record

Procedure method: Award procedure without prior publication of a call for competition
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Direct award (no call for competition)
GPA / WTO covered: Unspecified in notice
Recurring procurement: Unspecified in notice
First published: 15 Apr 2021, 10:22 BST
Last source update: 15 Apr 2021, 10:22 BST
Authority reference: DN535566
FTS notice number: 2021/S 000-007875
Classification (CPV): Medical equipments, pharmaceuticals and personal care products
Delivery area: London (UKI)
Official registry OCID: ocds-h6vhtk-02a634 Find a Tender

Why no open competition: The procurement falls outside the scope of application of the directive
Published justification: AAA Netspot vials is a Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours. A radioactive diagnostic agent for positron emission tomography (PET) imaging of somatostatin receptor overexpression in adult patients with confirmed or suspected somatostatin receptor positive
neuroendocrine tumors (NETs) for localizing primary tumours and their metastases.
This innovative technology supports a more accurate diagnosis and staging of NETs and a more tailored treatment plan

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 1

Awarded value £475,2001 contract exc. VAT

Contracts signed 1latest 7 Apr 2021

Awarded to	Value	Date	Status
Advance Accelerator Applications	£475,200 †	—	Awarded

Contracts

Contract 007875-2021-1 · Advance Accelerator Applications
Signed
7 Apr 2021
Value
£475,200
Status
active

Contracting authority & participating public bodies

The Royal Marsden NHS Foundation Trusts

Contracting authorityNHS & healthcareBody governed by public lawHealth Harbour Yard, London, London, SW10 0XDContact name, email

Dispute resolution & review bodies

High CourtReview body London

Bidders & participating suppliers

2 commercial parties on the notice

Advance Accelerator ApplicationsAwarded supplier London, London, NW1 5QT
Advance Accelerator ApplicationsAwarded supplier London, London

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.